retatrutide obesity triple hormone receptor agonist ⭐️topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon agonist, in adults with or “overweight” Retatrutide—A Game Changer in Obesity

Increased red cell distribution width is associated with disease severity in hospitalized adults with SARS-CoV-2 infection: an observational multicentric study

A landmark randomized, double-blind, placebo-controlled Phase 2 study conducted in the United States enrolled 338 adults with obesity or overweight conditions across multiple dosing regimens

Dysfunctional cellular autophagy

Mediterranean diet and changes in sleep duration and indicators of sleep quality in older adults

Voy, whose registered name is Menwell, sent three emails in November 2025 that breached the CAP Code for non-broadcast marketing, said the Advertising Standards Authority (ASA) in a ruling published today (May 27)